The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

(Reuters) -Johnson & Johnson said on Monday it would buy privately held Halda Therapeutics for $3.05 billion in cash, aiming ...

With the future of mRNA vaccines secure, an expert discusses the benefits of vaccine platform diversification.

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

With the greater part of third quarter earnings results in the rearview mirror, investors are looking closely at marquee ...

The new plant will allow the company to execute end-to-end clinical- and commercial-stage production of its mRNA medicines.

A bipartisan report warned Congress about China’s growing control over the pharmaceutical supply chain. Elsewhere, Alkermes sweetened its bid for Avadel and Moderna is investing $140 million in U.S.

Three out of four adults in the United States live with conditions that can increase the risk of severe illness. 9 Chronic ...

Moderna is investing more than $140 million to bring drug manufacturing to its Massachusetts campus, a move that it says will ...

Moderna (MRNA) announced on Wednesday that it has completed its domestic end-to-end mRNA manufacturing network with the ...

With the greater part of third quarter earnings results in the rearview mirror, investors are looking ahead to marquee ...

Corona Virus Vaccine Latest News and Updates, Special Reports, Videos & Photos of Corona Virus Vaccine on India TV. Articles on Corona Virus Vaccine, Complete Coverage on Corona Virus Vaccine ...